Valneva Se Adr Stock Current Valuation
| VALN Stock | USD 4.42 0.25 5.35% |
Valuation analysis of Valneva SE ADR helps investors to measure Valneva SE's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 21st of November 2024, Enterprise Value Over EBITDA is likely to drop to -25.16. In addition to that, Enterprise Value Multiple is likely to drop to -25.16. Fundamental drivers impacting Valneva SE's valuation include:
Price Book 1.6437 | Enterprise Value 412.4 M | Enterprise Value Ebitda 18.3679 | Price Sales 2.3915 | Forward PE 666.6667 |
Undervalued
Today
Please note that Valneva SE's price fluctuation is somewhat reliable at this time. Calculation of the real value of Valneva SE ADR is based on 3 months time horizon. Increasing Valneva SE's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Valneva SE is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Valneva Stock. However, Valneva SE's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.42 | Real 8.15 | Target 18.75 | Hype 4.59 | Naive 4.42 |
The intrinsic value of Valneva SE's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Valneva SE's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Valneva SE ADR helps investors to forecast how Valneva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Valneva SE more accurately as focusing exclusively on Valneva SE's fundamentals will not take into account other important factors: Valneva SE ADR Company Current Valuation Analysis
Valneva SE's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Valneva SE Current Valuation | 412.41 M |
Most of Valneva SE's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valneva SE ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Valneva Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Valneva SE is extremely important. It helps to project a fair market value of Valneva Stock properly, considering its historical fundamentals such as Current Valuation. Since Valneva SE's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Valneva SE's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Valneva SE's interrelated accounts and indicators.
Click cells to compare fundamentals
Valneva Current Valuation Historical Pattern
Today, most investors in Valneva SE Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Valneva SE's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Valneva SE current valuation as a starting point in their analysis.
Valneva SE Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Valneva SE ADR has a Current Valuation of 412.41 M. This is 97.13% lower than that of the Biotechnology sector and 91.12% lower than that of the Health Care industry. The current valuation for all United States stocks is 97.52% higher than that of the company.
Valneva Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Valneva SE's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Valneva SE could also be used in its relative valuation, which is a method of valuing Valneva SE by comparing valuation metrics of similar companies.Valneva SE is currently under evaluation in current valuation category among its peers.
Valneva SE Current Valuation Drivers
We derive many important indicators used in calculating different scores of Valneva SE from analyzing Valneva SE's financial statements. These drivers represent accounts that assess Valneva SE's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Valneva SE's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.2B | 2.0B | 4.8B | 1.4B | 1.3B | 932.4M | |
| Enterprise Value | 2.2B | 1.9B | 4.5B | 1.2B | 1.4B | 923.1M |
Valneva SE ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Valneva SE's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Valneva SE's managers, analysts, and investors.Environmental | Governance | Social |
Valneva Fundamentals
| Return On Equity | -0.0396 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 412.41 M | ||||
| Shares Outstanding | 81.18 M | ||||
| Shares Owned By Institutions | 1.16 % | ||||
| Number Of Shares Shorted | 48.21 K | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 2.39 X | ||||
| Revenue | 153.71 M | ||||
| Gross Profit | (68.06 M) | ||||
| EBITDA | (57.72 M) | ||||
| Net Income | (101.43 M) | ||||
| Cash And Equivalents | 336.22 M | ||||
| Cash Per Share | 5.74 X | ||||
| Total Debt | 208.82 M | ||||
| Debt To Equity | 1.43 % | ||||
| Current Ratio | 1.15 X | ||||
| Book Value Per Share | 1.55 X | ||||
| Cash Flow From Operations | (202.74 M) | ||||
| Short Ratio | 3.11 X | ||||
| Earnings Per Share | (0.13) X | ||||
| Target Price | 15.85 | ||||
| Number Of Employees | 676 | ||||
| Beta | 1.02 | ||||
| Market Capitalization | 379.13 M | ||||
| Total Asset | 460.06 M | ||||
| Retained Earnings | (561.2 M) | ||||
| Working Capital | 103.96 M | ||||
| Net Asset | 460.06 M |
About Valneva SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Valneva SE ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valneva SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valneva SE ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Valneva SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Valneva SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will appreciate offsetting losses from the drop in the long position's value.Moving together with Valneva Stock
| 0.84 | VRAX | Virax Biolabs Group | PairCorr |
| 0.69 | VRPX | Virpax Pharmaceuticals | PairCorr |
| 0.77 | DYN | Dyne Therapeutics | PairCorr |
Moving against Valneva Stock
| 0.81 | PRAX | Praxis Precision Med | PairCorr |
| 0.77 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.75 | VRDN | Viridian Therapeutics | PairCorr |
| 0.74 | AMLX | Amylyx Pharmaceuticals | PairCorr |
| 0.67 | AKRO | Akero Therapeutics | PairCorr |
The ability to find closely correlated positions to Valneva SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Valneva SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Valneva SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Valneva SE ADR to buy it.
The correlation of Valneva SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Valneva SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Valneva SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Valneva SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Valneva SE Piotroski F Score and Valneva SE Altman Z Score analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share 2.3 | Quarterly Revenue Growth 0.204 | Return On Assets (0.11) | Return On Equity (0.04) |
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.